摘要在2013年比利时临床化学学会年度研讨会上发表。

IF 1.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Acta Clinica Belgica Pub Date : 2014-06-01 DOI:10.1179/0001551214Z.00000000067
{"title":"摘要在2013年比利时临床化学学会年度研讨会上发表。","authors":"","doi":"10.1179/0001551214Z.00000000067","DOIUrl":null,"url":null,"abstract":"s presented at the 2013 Annual Symposium of the Belgische Vereniging voor Klinische Chemie, Société Belge de Chimie Clinique ANNUAL SYMPOSIUM 2013 B1: Evaluation of the Roche cobas b101 pointof-care instrument for glycated hemoglobin testing in an ambulant hospital setting S. Jonckheere, M. Langlois AZ Sint-Jan Brugge-Oostende AV Background: Hemoglobin A1c (HbA1c) is currently used both for monitoring and diagnosing patients with diabetes mellitus. Point-of-care (POC) instruments have been proposed to improve the glycemic control of patients with diabetes by providing a rapid result if the analytical performance is acceptable. In this study, we evaluated the Roche cobas b101, a new HbA1c POC device. Methods: Precision was determined by testing both control material supplied by the manufacturer and patient blood samples. Accuracy was investigated by method comparison on 154 outpatients attending the diabetic clinic using two different lot numbers. Two certified secondary reference methods were used as comparator. Results: Total CV’s ranged from 2.4 to 7.4% using the NGSP units (%) and from 3.3 to 11.2% using the IFCC units (mmol/mol), respectively. A rather modest correlation (r50.934) and a clinically relevant negative bias of 25.75 mmol/mol (20.53%-DCCT) was observed between the cobas b101 and the mean of the secondary reference methods. Moreover, considerable lot number variability was noticed. Conclusions: The performance of the cobas b101 was insufficient according to the current quality specifications for HbA1c. We believe that both for monitoring and for diagnosis of diabetes, the cobas b101 POC device does not provide the quality needed. B2: Performance characteristics of faecal calprotectin testing for diagnosis of Inflammatory Bowel Disease M. Oyaert, C. Trouvé, F. Baert, D. De Smet, M. Langlois, H. Vanpoucke Clinical Laboratory, AZ Delta Roeselare-Menen, Department of Laboratory Medicine, AZ St-Jan Brugge Oostende, Department of Gastro Enterology, AZ Delta Roeselare Menen Acta Clinica Belgica 2014 DOI 10.1179/0001551214Z.00000000067 Acta Clinica Belgica 2014 VOL. 69 SUPPL 2 S2-","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/0001551214Z.00000000067","citationCount":"0","resultStr":"{\"title\":\"Abstracts presented at the 2013 Annual Symposium of the Belgische Vereniging voor Klinische Chemie, Société Belge de Chimie Clinique.\",\"authors\":\"\",\"doi\":\"10.1179/0001551214Z.00000000067\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"s presented at the 2013 Annual Symposium of the Belgische Vereniging voor Klinische Chemie, Société Belge de Chimie Clinique ANNUAL SYMPOSIUM 2013 B1: Evaluation of the Roche cobas b101 pointof-care instrument for glycated hemoglobin testing in an ambulant hospital setting S. Jonckheere, M. Langlois AZ Sint-Jan Brugge-Oostende AV Background: Hemoglobin A1c (HbA1c) is currently used both for monitoring and diagnosing patients with diabetes mellitus. Point-of-care (POC) instruments have been proposed to improve the glycemic control of patients with diabetes by providing a rapid result if the analytical performance is acceptable. In this study, we evaluated the Roche cobas b101, a new HbA1c POC device. Methods: Precision was determined by testing both control material supplied by the manufacturer and patient blood samples. Accuracy was investigated by method comparison on 154 outpatients attending the diabetic clinic using two different lot numbers. Two certified secondary reference methods were used as comparator. Results: Total CV’s ranged from 2.4 to 7.4% using the NGSP units (%) and from 3.3 to 11.2% using the IFCC units (mmol/mol), respectively. A rather modest correlation (r50.934) and a clinically relevant negative bias of 25.75 mmol/mol (20.53%-DCCT) was observed between the cobas b101 and the mean of the secondary reference methods. Moreover, considerable lot number variability was noticed. Conclusions: The performance of the cobas b101 was insufficient according to the current quality specifications for HbA1c. We believe that both for monitoring and for diagnosis of diabetes, the cobas b101 POC device does not provide the quality needed. B2: Performance characteristics of faecal calprotectin testing for diagnosis of Inflammatory Bowel Disease M. Oyaert, C. Trouvé, F. Baert, D. De Smet, M. Langlois, H. Vanpoucke Clinical Laboratory, AZ Delta Roeselare-Menen, Department of Laboratory Medicine, AZ St-Jan Brugge Oostende, Department of Gastro Enterology, AZ Delta Roeselare Menen Acta Clinica Belgica 2014 DOI 10.1179/0001551214Z.00000000067 Acta Clinica Belgica 2014 VOL. 69 SUPPL 2 S2-\",\"PeriodicalId\":48865,\"journal\":{\"name\":\"Acta Clinica Belgica\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2014-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1179/0001551214Z.00000000067\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Clinica Belgica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1179/0001551214Z.00000000067\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Clinica Belgica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1179/0001551214Z.00000000067","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Abstracts presented at the 2013 Annual Symposium of the Belgische Vereniging voor Klinische Chemie, Société Belge de Chimie Clinique.
s presented at the 2013 Annual Symposium of the Belgische Vereniging voor Klinische Chemie, Société Belge de Chimie Clinique ANNUAL SYMPOSIUM 2013 B1: Evaluation of the Roche cobas b101 pointof-care instrument for glycated hemoglobin testing in an ambulant hospital setting S. Jonckheere, M. Langlois AZ Sint-Jan Brugge-Oostende AV Background: Hemoglobin A1c (HbA1c) is currently used both for monitoring and diagnosing patients with diabetes mellitus. Point-of-care (POC) instruments have been proposed to improve the glycemic control of patients with diabetes by providing a rapid result if the analytical performance is acceptable. In this study, we evaluated the Roche cobas b101, a new HbA1c POC device. Methods: Precision was determined by testing both control material supplied by the manufacturer and patient blood samples. Accuracy was investigated by method comparison on 154 outpatients attending the diabetic clinic using two different lot numbers. Two certified secondary reference methods were used as comparator. Results: Total CV’s ranged from 2.4 to 7.4% using the NGSP units (%) and from 3.3 to 11.2% using the IFCC units (mmol/mol), respectively. A rather modest correlation (r50.934) and a clinically relevant negative bias of 25.75 mmol/mol (20.53%-DCCT) was observed between the cobas b101 and the mean of the secondary reference methods. Moreover, considerable lot number variability was noticed. Conclusions: The performance of the cobas b101 was insufficient according to the current quality specifications for HbA1c. We believe that both for monitoring and for diagnosis of diabetes, the cobas b101 POC device does not provide the quality needed. B2: Performance characteristics of faecal calprotectin testing for diagnosis of Inflammatory Bowel Disease M. Oyaert, C. Trouvé, F. Baert, D. De Smet, M. Langlois, H. Vanpoucke Clinical Laboratory, AZ Delta Roeselare-Menen, Department of Laboratory Medicine, AZ St-Jan Brugge Oostende, Department of Gastro Enterology, AZ Delta Roeselare Menen Acta Clinica Belgica 2014 DOI 10.1179/0001551214Z.00000000067 Acta Clinica Belgica 2014 VOL. 69 SUPPL 2 S2-
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Acta Clinica Belgica
Acta Clinica Belgica MEDICINE, GENERAL & INTERNAL-
CiteScore
3.50
自引率
0.00%
发文量
44
期刊介绍: Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine primarily publishes papers on clinical medicine, clinical chemistry, pathology and molecular biology, provided they describe results which contribute to our understanding of clinical problems or describe new methods applicable to clinical investigation. Readership includes physicians, pathologists, pharmacists and physicians working in non-academic and academic hospitals, practicing internal medicine and its subspecialties.
期刊最新文献
Immune landscape in the glomerular transcriptome of nephrotic syndrome and anca-associated vasculitis. Expansion of MALDI-TOF MS database as a strategy for identification of Haemophilus species other than H. influenzae. A characterization of the HIV population with limited/exhausted treatment options: a multicenter Belgian study. Hypomagnesemia may be related to frailty, gait and balance problems, and basic activities of daily living in older adults. Case report: thyrotoxic periodic paralysis, an unusual cause of hypokalemia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1